| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.083 | 0.1 |